What will Amgen say during their next earnings call?

GLP-1 / GLP: If GLP-1 / GLP is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Dazodalibep: If Dazodalibep is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. VESALIUS-CV: If VESALIUS-CV is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Eosinophilic: If Eosinophilic is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Medicare: If Medicare is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Imfinzi / Durvalumab: If Imfinzi / Durvalumab is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. ESMO: If ESMO is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Artificial Intelligence (3+ times): If Artificial Intelligence (3+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Patent (2+ times): If Patent (2+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Tavneos: If Tavneos is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Acquisition: If Acquisition is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Litigation: If Litigation is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Oral (3+ times): If Oral (3+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Prolia (2+ times): If Prolia (2+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. Buyback / Buy Back: If Buyback / Buy Back is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. How this is resolved Video of Amgen earnings call. If a consensus by Kalshi employees cannot be reached using video, transcripts of Amgen earnings call will be used according to the news publications listed in the contract. Payout criteria The exact phrase/word, or a plural or possessive form of the phrase/word. Doesn't count for payout Grammatical/tense inflections. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the Amgen corporation. All trademarks, logos, and brand names are the property of their respective owners.